|
|
|
Cerus Corporation (NASDAQ: CERS) |
|
Cerus Corporation
CERS's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Looking into Cerus growth rates, revenue grew
by 8.7 % in IV. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2115
Medical Equipment & Supplies industry recorded
growth of revenues by 0.43 %
Cerus net loss increased from $-1 millions, to $-3 millions in IV. Quarter 2024,
• More on CERS's Growth
|
|
Cerus
realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 35.41 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 1.58.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.17.
• More on CERS's Valuation
|
|
|
|
|
Cerus
realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 35.41 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 1.58.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.17.
Cerus Price to Book Ratio is at 5.05 higher than Industry Avg. of -757.67, and higher than S&P 500 Avg. of 0.01
• More on CERS's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
